Pascual Alonso, A. (2023). Study of expression levels in MECP2 related disorders using transcriptomics and proteomics: Characterizing Rett syndrome and MECP2 duplication syndrome.
Citación estilo ChicagoPascual Alonso, Ainhoa. Study of Expression Levels in MECP2 Related Disorders Using Transcriptomics and Proteomics: Characterizing Rett Syndrome and MECP2 Duplication Syndrome. 2023.
Cita MLAPascual Alonso, Ainhoa. Study of Expression Levels in MECP2 Related Disorders Using Transcriptomics and Proteomics: Characterizing Rett Syndrome and MECP2 Duplication Syndrome. 2023.
Precaución: Estas citas no son 100% exactas.